Reducing Inequity in the Use of Automated Insulin Delivery Systems by Adults With Type 1 Diabetes: Key Learnings From a Safety Net Diabetes Clinic Program
Authors' conclusion
The program's success among minoritized patients underscores the significance of tailored, collaborative, team-based care and targeted educational initiatives. Our experience provides a foundation for future efforts to ensure equitable access to diabetes technologies, emphasizing the potential of local quality improvement interventions.
Study context
- Population
- Adults with T1D at Boston Medical Center, the largest safety-net hospital in New England; referred population 49% female, mean A1c 8.7%, 68% public insurance beneficiaries, 25% Hispanic and 25% non-Hispanic Blackreferred
- Participants
- 97 adults
- Outcome
- AID system use
- Follow-up
- First year
Methodological detailssingle-centre, multidisciplinary team, Strategies: increased access to diabetes educators, a referral system, telemedicine education classes and efforts to raise clinician awareness and confidence in recommending AID therapy
- Single-centre
- Multidisciplinary team
- Strategies: increased access to diabetes educators, a referral system, telemedicine education classes and efforts to raise clinician awareness and confidence in recommending AID therapy
Main finding
As reported in the abstract
Increase in AID system use rates
166%
Referred patients starting on AID
64%
Further findings
Insulin pump use at baseline
- Clinic T1D population using an insulin pump
- 13.5%
AID adoption in patients with A1c >8.5% · first year
- Patients with A1c >8.5% who adopted AID systems
- 78%
Disparities in AID use
- Disparities in AID use among minoritized populations narrowed
Original publication
Reducing Inequity in the Use of Automated Insulin Delivery Systems by Adults With Type 1 Diabetes: Key Learnings From a Safety Net Diabetes Clinic Program. Endocr Pract. Published 5 April 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →